TheraDep introduces BioDep, a new range of medical-grade collagen-coated microplates produced using our proprietary BioDep biosurface coating technology. This approach deposits an ultra-thin, nano-scale layer of superior medical-grade bovine collagen. The base material having its native triple-helix structure and fibrillar architecture that are essential for biological function. Clinically trusted in over 40 million procedures, BioDep collagen has been shown to support precise cell signaling, minimizes inflammation. It also is a rejection risk, promotes natural healing, hemostasias, and tissue integration. The nano-layer coating maximizes performance while reducing material use, supporting both biological function and sustainability.
BioDep collagen-coated microplates are foundational tools for live cell-based assays, delivering physiologically relevant surfaces that enhance cell attachment, migration, growth, and differentiation. Collagen coated plates are widely used across key markets including drug discovery and toxicology screening, cancer biology, regenerative medicine, cell and gene therapy development, and advanced 3D and organoid models. Researchers can rely on BioDep plates for critical applications such as stem cell differentiation, angiogenesis, neurobiology, and tissue morphogenesis, where native extracellular matrix signaling is essential. By bridging cell biology and medical device innovation, BioDep enables more predictive, reproducible, and translational in-vitro research.
